Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Supernus Pharmaceuticals, Inc.
- scPharmaceuticals Inc.
Updated Jul 16, 2026
Hudson Frederick M. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $903K.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-16 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale | 5.4K | $50.61 | $272K |
| 2026-02-25 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | A — Grant or award | 4.5K | $0.00 | |
| 2025-08-14 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale | 7.5K | $42.26 | $315K |
| 2024-11-12 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | S — Open-market sale | 8.7K | $36.28 | $316K |
Hudson Frederick M. is a corporate insider — currently tracked as Director. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($903K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hudson Frederick M. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.